Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
53,041,500
-
Total 13F shares
-
25,011,926
-
Share change
-
+2,639,799
-
Total reported value
-
$1,750,112,005
-
Put/Call ratio
-
46%
-
Price per share
-
$69.98
-
Number of holders
-
163
-
Value change
-
+$227,704,225
-
Number of buys
-
110
-
Number of sells
-
63
Institutional Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q2 2020
As of 30 Jun 2020,
Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) was held by
163 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,011,926 shares.
The largest 10 holders included
CAS Investment Partners, LLC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., VANGUARD GROUP INC, KPS Global Asset Management UK Ltd, 683 Capital Management, LLC, WELLS FARGO & COMPANY/MN, MORGAN STANLEY, TYBOURNE CAPITAL MANAGEMENT (HK) LTD, and Antipodean Advisors LLC.
This page lists
163
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.